Showing results (161-170 of 191) with videos related to
Sort By:
Pageof 20
Bioconjugate Chemistry|July 1, 1997
Development of a streptavidin-anti-carcinoembryonic antigen antibody, radiolabeled biotin pretargeting method for radioimmunotherapy of colorectal cancer. Reagent developmentH Karacay, R M Sharkey, S V Govindan, et al.Journal of Neurology, Neurosurgery, and Psychiatry|April 20, 2004
Multicentre, randomised, double blind, placebo controlled, phase III study of weekly, low dose, subcutaneous interferon beta-1a in secondary progressive multiple sclerosisO Andersen, I Elovaara, M Färkkilä, et al.Gastroenterology|May 1, 1994
Normal colonic epithelium adheres to carcinoembryonic antigen and type IV collagenS Ishii, G Steele, R Ford, et al.Cancer|September 1, 1978
Evaluation of carcinoembryonic antigen as a plasma monitor for human breast carcinomaD E Haagensen, S J Kister, J P Vandevoorde, et al.Cancer Research|December 1, 1995
Development and evaluation of the specificity of a rat monoclonal anti-idiotype antibody, WN, to an anti-B-cell lymphoma monoclonal antibody, LL2M J Losman, S O Leung, L B Shih, et al.Clinical Chemistry|January 1, 1989
Solving the problem of antibody interference in commercial "sandwich"-type immunoassays of carcinoembryonic antigenH J Hansen, G LaFontaine, E S Newman, et al.Bioconjugate Chemistry|September 19, 2002
Pretargeting for cancer radioimmunotherapy with bispecific antibodies: role of the bispecific antibody's valency for the tumor target antigenH Karacay, R M Sharkey, W J McBride, et al.International Journal of Cancer|February 8, 1995
Effect of VK framework-1 glycosylation on the binding affinity of lymphoma-specific murine and chimeric LL2 antibodies and its potential use as a novel conjugation siteS O Leung, A S Dion, M C Pellegrini, et al.Bioconjugate Chemistry|March 17, 1999
Labeling of monoclonal antibodies with diethylenetriaminepentaacetic acid-appended radioiodinated peptides containing D-amino acidsS V Govindan, M J Mattes, R Stein, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 30, 1999
The effects of domain deletion, glycosylation, and long IgG3 hinge on the biodistribution and serum stability properties of a humanized IgG1 immunoglobulin, hLL2, and its fragmentsS O Leung, Z Qu, H J Hansen, et al.Pageof 20